PharVision Advisers LLC Buys Shares of 107,691 Herbalife Ltd. (NYSE:HLF)

PharVision Advisers LLC bought a new stake in shares of Herbalife Ltd. (NYSE:HLF - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 107,691 shares of the company's stock, valued at approximately $720,000. Herbalife accounts for about 0.6% of PharVision Advisers LLC's investment portfolio, making the stock its 14th largest position. PharVision Advisers LLC owned about 0.11% of Herbalife as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of HLF. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Herbalife by 21.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 204,157 shares of the company's stock worth $1,366,000 after purchasing an additional 35,948 shares during the period. Two Sigma Advisers LP boosted its position in Herbalife by 1,583.5% during the fourth quarter. Two Sigma Advisers LP now owns 173,400 shares of the company's stock worth $1,160,000 after purchasing an additional 163,100 shares in the last quarter. State of Wyoming grew its holdings in Herbalife by 227.6% in the fourth quarter. State of Wyoming now owns 36,042 shares of the company's stock valued at $241,000 after purchasing an additional 25,040 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in shares of Herbalife in the fourth quarter valued at approximately $382,000. Finally, ProShare Advisors LLC increased its position in shares of Herbalife by 50.5% in the fourth quarter. ProShare Advisors LLC now owns 28,428 shares of the company's stock valued at $190,000 after buying an additional 9,545 shares in the last quarter.

Insider Activity at Herbalife

In related news, Director Juan Miguel Mendoza acquired 5,000 shares of Herbalife stock in a transaction that occurred on Friday, May 2nd. The shares were purchased at an average price of $6.73 per share, for a total transaction of $33,650.00. Following the completion of the transaction, the director now owns 140,000 shares in the company, valued at $942,200. This represents a 3.70% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders acquired 17,500 shares of company stock valued at $128,650. Corporate insiders own 1.73% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HLF. Citigroup dropped their price target on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. DA Davidson raised shares of Herbalife from a "neutral" rating to a "buy" rating and increased their price objective for the company from $7.50 to $14.00 in a report on Friday, March 21st. Finally, Wall Street Zen lowered shares of Herbalife from a "buy" rating to a "hold" rating in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $11.50.

Herbalife Stock Performance

Shares of NYSE:HLF traded down $0.30 during trading on Monday, reaching $6.67. The stock had a trading volume of 1,495,061 shares, compared to its average volume of 2,250,786. Herbalife Ltd. has a 1-year low of $5.04 and a 1-year high of $12.79. The stock has a market cap of $678.81 million, a PE ratio of 2.68, a PEG ratio of 0.29 and a beta of 0.88. The business has a fifty day moving average price of $7.28 and a 200-day moving average price of $7.21.

Herbalife (NYSE:HLF - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.19. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. The company had revenue of $1.22 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter in the previous year, the company posted $0.49 EPS. The firm's quarterly revenue was down 3.4% on a year-over-year basis. Sell-side analysts expect that Herbalife Ltd. will post 1.57 earnings per share for the current year.

Herbalife Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.